Cancer Researchers Scramble to Meet Demand for New Breast Cancer Drugs
STAT’s biotech columnist Adam Feuerstein and cancer journalist Angus Chen report on the crossroads of drug development, business, Wall Street, and biotechnology at the American Society of Oncology annual meeting. The event saw a surge in interest for new breast cancer treatments. A new round of promising breast cancer drugs is about to hit the … Read more